Keyphrases
Targeted Treatment
100%
Non-small Cell Lung Cancer (NSCLC)
100%
SN-38
100%
Anticancer Activity
33%
Tumor
16%
Anticancer Drugs
16%
High Efficiency
16%
Linker
16%
Hydroxyl Group
16%
Xenograft
16%
Topoisomerase Inhibitors
16%
Biological Evaluation
16%
Specific Antibodies
16%
Synthetic Evaluation
16%
Cyclic Peptide
16%
Succinate
16%
Targeted Cancer Therapy
16%
EGFR Positive
16%
Irinotecan
16%
Bioactive Metabolites
16%
Tumor Inhibition
16%
Cancer Xenograft
16%
Cetuximab
16%
E-ring
16%
Medicine and Dentistry
Targeted Therapy
100%
Epidermal Growth Factor Receptor
100%
Non Small Cell Lung Cancer
100%
SN-38
100%
Antineoplastic Activity
15%
Metabolite
7%
Neoplasm
7%
Tumor Progression
7%
Anticarcinogen
7%
Cell Line
7%
Cancer
7%
Xenograft
7%
Antibodies
7%
Conjugate
7%
Cyclopeptide
7%
Tumor Xenograft
7%
Molecularly Targeted Therapy
7%
Irinotecan
7%
Cetuximab
7%
Hydroxyl Group
7%
Succinic Acid
7%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Epidermal Growth Factor Receptor
100%
Firtecan
100%
Malignant Neoplasm
7%
Neoplasm
7%
Tumor Growth
7%
Anticarcinogen
7%
Succinic Acid
7%
Antibodies
7%
Cyclopeptide
7%
Hydroxyl Group
7%
Cetuximab
7%
Irinotecan
7%